Rett Syndrome Terminated Phase 2 / 3 Trials for Sarizotan (DB06454)

Also known as: Rett's Syndrome / Rett's Disorder / RTT / Rett Disorder / Rett's disorder (disorder)

IndicationStatusPhase
DBCOND0002561 (Rett Syndrome)Terminated2 / 3
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT02790034Evaluation of the Efficacy, Safety, and Tolerability of Sarizotan in Rett Syndrome With Respiratory SymptomsTreatment